333 related articles for article (PubMed ID: 28652236)
1. Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.
Lam H; Schwochert J; Lao Y; Lau T; Lloyd C; Luu J; Kooner O; Morgan J; Lokey S; Auerbuch V
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652236
[TBL] [Abstract][Full Text] [Related]
2. Developing Cyclic Peptomers as Broad-Spectrum Type III Secretion System Inhibitors in Gram-Negative Bacteria.
Lam HN; Lau T; Lentz A; Sherry J; Cabrera-Cortez A; Hug K; Lalljie A; Engel J; Lokey RS; Auerbuch V
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0169020. PubMed ID: 33875435
[TBL] [Abstract][Full Text] [Related]
3. An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.
Duncan MC; Wong WR; Dupzyk AJ; Bray WM; Linington RG; Auerbuch V
Antimicrob Agents Chemother; 2014; 58(2):1118-26. PubMed ID: 24295981
[TBL] [Abstract][Full Text] [Related]
4. Exploring resveratrol dimers as virulence blocking agents - Attenuation of type III secretion in Yersinia pseudotuberculosis and Pseudomonas aeruginosa.
Sundin C; Zetterström CE; Vo DD; Brkljača R; Urban S; Elofsson M
Sci Rep; 2020 Feb; 10(1):2103. PubMed ID: 32034212
[TBL] [Abstract][Full Text] [Related]
5. Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms.
Anantharajah A; Buyck JM; Sundin C; Tulkens PM; Mingeot-Leclercq MP; Van Bambeke F
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396545
[TBL] [Abstract][Full Text] [Related]
6. An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic
Morgan JM; Lam HN; Delgado J; Luu J; Mohammadi S; Isberg RR; Wang H; Auerbuch V
Front Cell Infect Microbiol; 2018; 8():404. PubMed ID: 30524970
[TBL] [Abstract][Full Text] [Related]
7. Genetic and Environmental Investigation of a Novel Phenylamino Acetamide Inhibitor of the Pseudomonas aeruginosa Type III Secretion System.
Fang L; Banerjee B; Yuan X; Zeng Q; Liang C; Chen X; Yang CH
Appl Environ Microbiol; 2023 Jan; 89(1):e0175222. PubMed ID: 36519869
[TBL] [Abstract][Full Text] [Related]
8. Piericidin A1 Blocks
Morgan JM; Duncan MC; Johnson KS; Diepold A; Lam H; Dupzyk AJ; Martin LR; Wong WR; Armitage JP; Linington RG; Auerbuch V
mSphere; 2017; 2(1):. PubMed ID: 28217742
[TBL] [Abstract][Full Text] [Related]
9. The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa.
Zetterström CE; Hasselgren J; Salin O; Davis RA; Quinn RJ; Sundin C; Elofsson M
PLoS One; 2013; 8(12):e81969. PubMed ID: 24324737
[TBL] [Abstract][Full Text] [Related]
10. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
Sheahan KL; Isberg RR
mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
[TBL] [Abstract][Full Text] [Related]
11. Vfr Directly Activates exsA Transcription To Regulate Expression of the Pseudomonas aeruginosa Type III Secretion System.
Marsden AE; Intile PJ; Schulmeyer KH; Simmons-Patterson ER; Urbanowski ML; Wolfgang MC; Yahr TL
J Bacteriol; 2016 May; 198(9):1442-50. PubMed ID: 26929300
[TBL] [Abstract][Full Text] [Related]
12. Bacterial internalization is required to trigger NIK-dependent NF-κB activation in response to the bacterial type three secretion system.
Duncan MC; Herrera NG; Johnson KS; Engel JN; Auerbuch V
PLoS One; 2017; 12(2):e0171406. PubMed ID: 28166267
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Protein-Protein Interface Inhibitors Allow Efficient Inhibition of Type III Secretion Machinery and
Ngo TD; Plé S; Thomas A; Barette C; Fortuné A; Bouzidi Y; Fauvarque MO; Pereira de Freitas R; Francisco Hilário F; Attrée I; Wong YS; Faudry E
ACS Infect Dis; 2019 Nov; 5(11):1843-1854. PubMed ID: 31525902
[No Abstract] [Full Text] [Related]
14. A Structure-Function-Inhibition Analysis of the
Moir DT; Bowlin NO; Berube BJ; Yabut J; Mills DM; Nguyen GT; Aron ZD; Williams JD; Mecsas J; Hauser AR; Bowlin TL
J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32601072
[TBL] [Abstract][Full Text] [Related]
15. H-NS Family Members MvaT and MvaU Regulate the Pseudomonas aeruginosa Type III Secretion System.
Williams McMackin EA; Marsden AE; Yahr TL
J Bacteriol; 2019 Jul; 201(14):. PubMed ID: 30782629
[No Abstract] [Full Text] [Related]
16. Epigallocatechin gallate inhibits the type III secretion system of Gram-negative enteropathogenic bacteria under model conditions.
Nakasone N; Higa N; Toma C; Ogura Y; Suzuki T; Yamashiro T
FEMS Microbiol Lett; 2017 Jul; 364(13):. PubMed ID: 28651361
[TBL] [Abstract][Full Text] [Related]
17. A Primed Subpopulation of Bacteria Enables Rapid Expression of the Type 3 Secretion System in Pseudomonas aeruginosa.
Lin CK; Lee DSW; McKeithen-Mead S; Emonet T; Kazmierczak B
mBio; 2021 Jun; 12(3):e0083121. PubMed ID: 34154400
[TBL] [Abstract][Full Text] [Related]
18. Fitting Pieces into the Puzzle of
Williams McMackin EA; Djapgne L; Corley JM; Yahr TL
J Bacteriol; 2019 Jul; 201(13):. PubMed ID: 31010903
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Type Three Secretion System in Pseudomonas aeruginosa.
Anantharajah A; Mingeot-Leclercq MP; Van Bambeke F
Trends Pharmacol Sci; 2016 Sep; 37(9):734-749. PubMed ID: 27344210
[TBL] [Abstract][Full Text] [Related]
20. Iron availability and oxygen tension regulate the Yersinia Ysc type III secretion system to enable disseminated infection.
Hooker-Romero D; Mettert E; Schwiesow L; Balderas D; Alvarez PA; Kicin A; Gonzalez AL; Plano GV; Kiley PJ; Auerbuch V
PLoS Pathog; 2019 Dec; 15(12):e1008001. PubMed ID: 31869388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
